Pluvia Biotech
PrivateLast Round
Seed
May 19, 2026
Total Funding Raised
$1.5M
Momentum
Top 5%
of companies Caplight tracks
Company Overview
Pluvia Biotech is a biotechnology company that develops oral pharmacological chaperones for the treatment of rare genetic disorders caused by protein misfolding, such as phenylketonuria (PKU).
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Pluvia Biotech Comparables
Compare Pluvia Biotech with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Atlas Molecular Pharma | 82% | |
| SOM Biotech | 81% | |
| Otsuka Holdings | 75% |
Pluvia Biotech Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Seed | May 19, 2026 | ||||
| Grant | Nov 25, 2025 | ||||
| Seed | Mar 1, 2017 |
Pluvia Biotech Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Investinor | Seed |
| Tidligfasekapital Vestland | Seed |
| Trond Mohn Research Foundation | Seed |
| Sarsia | Seed |
| MABA | Seed |
Market signals
Structured signals derived from secondary market and firmographic data.
- Aug 22, 2026
Monthly visitors grew 213% MoM, reaching 2.4K.
- May 19, 2026
Secured Seed funding from Investinor, Sarsia, and others.
Pluvia Biotech Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about Pluvia Biotech's valuation, stock price, and market status.
Is Pluvia Biotech a public or private company?
Pluvia Biotech is a private company.
What is the current stock price of Pluvia Biotech?
Pluvia Biotech is a private company with no public stock price. No recent secondary market data is available.
How much is Pluvia Biotech worth (valuation)?
Valuation information for Pluvia Biotech is not publicly available.
Can I buy Pluvia Biotech stock?
Pluvia Biotech shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.
When was Pluvia Biotech's last funding round?
Pluvia Biotech's most recent funding round was Seed on May 19, 2026.
Who are the main investors in Pluvia Biotech?
Key investors in Pluvia Biotech include Investinor, Tidligfasekapital Vestland, Trond Mohn Research Foundation, Sarsia, MABA.
Will Pluvia Biotech IPO soon?
No public IPO plans have been announced for Pluvia Biotech.
How can I track Pluvia Biotech secondary market activity?
Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Pluvia Biotech's secondary market activity and sign up for updates.